Central Trust Company’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3
Closed -$1.34K 1567
2025
Q3
$1.34K Sell
3
-3
-50% -$1.36K ﹤0.01% 1311
2025
Q2
$2.92K Sell
6
-2
-25% -$1.14K ﹤0.01% 1276
2025
Q1
$4.92K Hold
8
﹤0.01% 1213
2024
Q4
$4.24K Hold
8
﹤0.01% 1220
2024
Q3
$4.81K Hold
8
﹤0.01% 1159
2024
Q2
$4.34K Sell
8
-102
-93% -$58.4K ﹤0.01% 1188
2024
Q1
$70.6K Sell
110
-24
-18% -$14.6K ﹤0.01% 744
2023
Q4
$78.4K Sell
134
-8
-6% -$4.48K ﹤0.01% 715
2023
Q3
$73.8K Sell
142
-45
-24% -$23.4K ﹤0.01% 705
2023
Q2
$101K Sell
187
-34
-15% -$18.6K ﹤0.01% 666
2023
Q1
$119K Buy
221
+20
+10% +$10.2K ﹤0.01% 628
2022
Q4
$103K Buy
201
+58
+41% +$28.2K ﹤0.01% 641
2022
Q3
$62K Buy
143
+137
+2,283% +$65.9K ﹤0.01% 733
2022
Q2
$3K Hold
6
﹤0.01% 1162
2022
Q1
$3K Buy
+6
New +$2.88K ﹤0.01% 1195
2021
Q1
Sell
-342
Closed -$182K 1110
2020
Q4
$182K Sell
342
-1,293
-79% -$635K 0.01% 491
2020
Q3
$785K Sell
1,635
-54
-3% -$26.5K 0.04% 280
2020
Q2
$762K Sell
1,689
-78
-4% -$34.8K 0.04% 273
2020
Q1
$765K Sell
1,767
-8
-0.5% -$3.57K 0.05% 258
2019
Q4
$780K Buy
1,775
+28
+2% +$11.8K 0.04% 290
2019
Q3
$729K Buy
+1,747
New +$713K 0.04% 282

Other funds holding CHE

Central Trust Company's CHE Position: Q4 2025 in Review

Central Trust Company sold out of Chemed (CHE) in Q4 2025, closing a stake of 3 shares — an estimated $1.34K sold.

Central Trust Company first reported a position in CHE in Q3 2019 and held it in 21 quarters. The position peaked at $785K in Q3 2020. 516 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Central Trust Company reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Central Trust Company sold 3 Chemed shares in Q4 2025, an estimated $1.34K.
  • Central Trust Company first reported a position in Chemed in Q3 2019 and held it in 21 quarters.
  • Central Trust Company's Chemed position peaked at $785K in Q3 2020.
  • 516 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Central Trust Company's 13F filing for Q4 2025, filed 2 Feb 2026.